COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia.: Unprecedented times for patients with thalassemia

COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia.

Unprecedented times for patients with thalassemia

Authors

  • Shruti Kakkar a:1:{s:5:"en_US";s:7:"MBBS,MD";}
  • Vaneet Anand Junior Consultant, Pediatric Hematology Oncology, Dayanand Medical College and Hospital,Ludhiana
  • Priyanka Dewan Child Psychologist
  • Praveen Sobti Director, Guru Teg Bahadur Sahib Charitable Hospital, Ludhiana.

Keywords:

Thalassemia, Lockdown, Optimal management

References

Singh, P. How COVID-19 is endangering the lives of Thalassemia patients. National Herald. (2020, May 8). Retrieved from https://www.nationalheraldindia.com

Prasad, Narayan, Mansi Bhatt, Sanjay K Agarwal, et al. The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India. Kidney International Reports 2020; 5, Issue 9, 1545 – 1550.

Dehshal, M. H., Hosoya, S., Bahremani, et al. COVID-19 and Thalassaemia in Iran. Thalassemia Reports, 2020; 10(1). https://doi.org/10.4081/thal.2020.9157.

Eleftheriou, A., Cannon, L., & Angastiniotis, M. Thalassaemia prior and consequent to COVID-19 pandemic. The perspective of Thalassaemia International Federation (TIF). Thalassemia Reports, 2020; 10(1). https://doi.org/10.4081/thal.2020.9138.

Panigrahi M, Swain TR, Jena RK, et al. Effectiveness of Deferasirox in Pediatric Thalassemia Patients: Experience from a Tertiary Care Hospital of Odisha. Indian J Pharmacol 2020; 52:172-8.

Dhamija M, Mahajan A, Kalra M, et al. Deferasirox in Indian children with thalassemia major: 3 years experience. Indian J Med Paediatr Oncol. 2013;34(1):16-20. doi:10.4103/0971-5851.113407.

Downloads

Published

01-07-2021

Issue

Section

CORRESPONDENCE - SPECIAL COVID19

How to Cite

1.
Kakkar S, Anand V, Dewan P, Sobti P. COVID 19 pandemic and lockdown: A double whammy for patients with thalassemia.: Unprecedented times for patients with thalassemia. Acta Biomed. 2021;92(3):e2021212. doi:10.23750/abm.v92i3.10880